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Microglia, the main resident immune cells in the CNS, are thought to participate in the pathogenesis 
of various neurological disorders. LPS and LPS + IFNγ are stimuli that are widely used to activate 
microglia. However, the transcriptomic profiles of microglia treated with LPS and LPS + IFNγ have 
not been properly compared. Here, we treated murine primary microglial cultures with LPS or 
LPS + IFNγ for 6 hours and then performed RNA-Sequencing. Gene expression patterns induced by 
the treatments were obtained by WGCNA and 11 different expression profiles were found, showing 
differential responses to LPS and LPS + IFNγ in many genes. Interestingly, a subset of genes involved 
in Parkinson’s, Alzheimer’s and Huntington’s disease were downregulated by both treatments. By 
DESeq analysis we found differentially upregulated and downregulated genes that confirmed LPS 
and LPS + IFNγ as inducers of microglial pro-inflammatory responses, but also highlighted their 
involvement in specific cell functions. In response to LPS, microglia tended to be more proliferative, 
pro-inflammatory and phagocytic; whereas LPS + IFNγ inhibited genes were involved in pain, cell 
division and, unexpectedly, production of some inflammatory mediators. In summary, this study 
provides a detailed description of the transcriptome of LPS- and LPS + IFNγ treated primary microglial 
cultures. It may be useful to determine whether these in vitro phenotypes resemble microglia in in vivo 
pathological conditions.
Microglia are the main cells of myeloid origin in the central nervous system (CNS). They are considered 
tissue-resident macrophages that constantly patrol the cerebral microenvironment and respond to pathogens and 
cell damage1. Microglia responses to changes in homeostasis are highly plastic and multifaceted: finely tuned by 
the nature of the disturbance2. One of the most widely used stimuli to elicit inflammatory microglia is lipopoly-
saccharide (LPS) alone or in combination with interferon gamma (IFNγ).
LPS is the main structural component of the outer membrane of Gram-negative bacteria. It is a heat-stable, 
amphiphilic molecule comprising three regions: lipid A, a core oligosaccharide and an O side chain3. The primary 
receptor of LPS is Tlr4, which is a pivotal contributor to the microglial response to endotoxins, and is involved in 
LPS-mediated neurodegeneration4. In vitro, LPS-treated microglia produce pro-inflammatory mediators, such as 
Tnf, Il-1β, prostaglandin E2, NO and reactive oxygen species (ROS) (reviewed in Schwartz et al.5). LPS has been 
used to study the involvement of neuroinflammation in experimental models of Parkinson’s and Alzheimer’s 
disease, as well as amyotrophic lateral sclerosis (reviewed in Ransohoff & Perry6 and Nayak et al.7). Specifically, 
neuron-microglia co-cultures treated with LPS are a powerful tool to study the mechanisms involved in the dopa-
minergic neuronal death observed in Parkinson’s disease. In vivo, injection of LPS into the substantia nigra also 
results in the progressive and irreversible loss of dopaminergic neurons. In both cases, LPS triggers rapid activa-
tion of microglia, which precedes neuronal death. Therefore, LPS-treated microglia constitute a suitable system 
for the screening of therapeutic targets against neurodegeneration8.
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IFNγ mediates immune and inflammatory responses by activating transcription factor STAT1 through the 
JAK-STAT signalling pathway. Interestingly, many IFNγ functions are mediated by cross-regulation of cellular 
responses to other inflammatory stimuli9. Therefore, IFNγ has been used together with LPS to mimic a micro-
glial activation state that could be induced in vivo by the co-presence of damage-associated molecular patterns 
acting on TLRs, together with IFNγ produced by CNS cells. LPS + IFNγ treatment induces the production of 
pro-inflammatory mediators in the BV2 microglial cell line and in primary microglial cells10. However, whereas 
in some cases IFNγ potentiates the effect of LPS, e.g., NO production; in others, IFNγ counteracts it, e.g., Ptges 
and Csf3 expression11. These results indicate that two stimuli are capable of activating different pathways and they 
are not redundant.
Since modelling neuroinflammation and microglial activation in vitro constitutes a valuable tool to study the 
role of microglia under normal and pathological conditions, it is important to know how LPS and LPS + IFNγ 
affect microglia. In order to analyse the expression pattern of genes affected by these stimuli, we performed 
RNA-Sequencing analysis (RNA-Seq) on primary microglial cells stimulated with LPS or LPS + IFNγ. RNA-Seq 
is increasingly used to determine gene expression, since it provides unbiased expression profiles, identifies novel 
transcribed regions and is extremely accurate in comparison to RNA microarrays12.
Different methodologies have been developed to analyze RNA-Seq data in recent years. Here, we use DESeq 
to detect differentially expressed genes (DEGs), i.e., genes that are significantly upegulated or downregulated in 
pairwise comparisons, in murine primary microglia treated with vehicle, LPS or LPS + IFNγ. Additionally, we 
also use a different data analysis approach termed weighted gene correlation network analysis (WGCNA), which 
measures the correlation among genes, regardless of significance. Furthermore, since this approach compares 
all the genes in the data, it can infer complex expression patterns that could easily be overlooked in the pairwise 
differential expression analysis. Both, DESeq and WGCNA revealed that not all genes are equally affected by LPS 
and LPS + IFNγ. Therefore, our results confirm that the two stimuli generate distinct gene expression patterns 
and can constitute useful tools to induce different profiles of inflammation in microglia.
Materials and Methods
Animals. Phenotypically wild-type C/EBPβfl/fl mice on a C57BL/6J background (Jackson Laboratories) were 
breed and housed under specific pathogen-free conditions in the animal facilities at the School of Medicine, 
University of Barcelona. They received food and water ad libitum. All procedures were approved by the Ethical 
Committee for Animal Experimentation of the University of Barcelona and by the Commission for Animal 
Experimentation of the Generalitat de Catalunya, with protocols numbers DAAM 5026, 7064 and 7065.
Primary microglial cultures. Microglial primary cultures were prepared as described previously11. Briefly, 
cortices from P1-P3 mice were dissected, carefully stripped of their meninges and digested with 0.25% trypsin for 
30 min at 37 °C. Trypsinization was stopped by adding an equal volume of culture medium (Dulbecco’s modified 
Eagle medium-F-12 nutrient mixture, fetal bovine serum 10%, penicillin 100 U/mL, streptomycin 100 μg/mL 
and amphotericin B 0.5 μg/mL) with 160 µg/mL deoxyribonuclease I, all from Invitrogen. Cells were brought to a 
single cell suspension by repeated pipetting followed by passage through a 100 μm-pore mesh and pelleted (7 min, 
200 g). Glial cells were resuspended in culture medium and seeded at a density of 3.5 × 105 cells/mL. Cultures 
were maintained at 37 °C in humidified 5% CO2–95% air. Medium was replaced once a week. At DIV 20, mixed 
glial cultures were treated with diluted trypsin13 to obtain >98% pure microglial cultures. Microglial cells were 
used 24 h after isolation.
Cell treatment and total RNA isolation. Three independent microglial cultures were treated for 6 h with 
vehicle (cell culture medium) and 100 ng/mL of LPS (026:B6 Escherichia coli serotype, Sigma Aldrich) with or 
without 1 ng/mL of recombinant mouse IFNγ (I4777, Sigma Aldrich). Then, total RNA was isolated by lysing pel-
leted microglial cells from one 75 cm2 flask per treatment condition with 1 mL of TriReagent (Sigma Aldrich) and 
100 µl of 1-bromo-3-chloropropane (BCP, Sigma Aldrich). The aqueous phase containing total RNA was recov-
ered after centrifuging for 15 min at 12.000 g at 4 °C, mixed with and equal volume of ice-cold 70% Ethanol and 
loaded onto a PureLinkTM Micro Kit column (Invitrogen). Total RNA was then purified following manufacturer’s 
instructions. Total RNA was quantified spectrophotometrically using a Nano Drop ND-1000 (Thermo Scientific) 
and its integrity and quality were assessed with the Bioanalyzer 2100 system (Agilent). Only samples with an RNA 
integrity number (RIN) greater than 8 were used subsequently for RNAseq and qRT-PCR analyses.
qRT-PCR. 300 ng of total RNA were used to carry out reverse transcription reactions with random primers 
using Transcriptor Reverse Transcriptase (Roche). Then, cDNA was diluted 1/30 and 3 µl were used to perform 
quantitative real-time PCR (qRT-PCR) with qPCRBIO Sygreen Mix Lo-ROX (PCB-P20.11–50, Vitro) in 15 µl 
of final volume reaction using CFX96 Thermal Cycler equipment (Bio-Rad). Measurements were performed in 
duplicates. Primers, shown in Table 1, were used at final concentration of 300 nM. Actin-β and Rn18s expression 
was not altered by treatments (data not shown). Samples were run for 45 cycles (95 °C for 30 seconds, 60 °C or 
62 °C for 1 minute and 72 °C for 30 seconds). Amplification specificity was confirmed by the analysis of melting 
curves and by agarose-gel electrophoresis. Relative gene expression values were calculated using Bio-Rad CFX 
Managing software (Bio-Rad) with the comparative Ct or ΔΔCt method.
cDNA library preparation and RNA-Seq. Following Illumina’s (San Diego, CA) protocols, cDNA library 
preparation and ultrasequencing were performed. The first step was removing transfer RNA (tRNA) and ribo-
somal RNA (rRNA) from 1 µg of total RNA using TruSeq Stranded Total RNA Sample Prep Kits (Illumina). 
Then, the RNA pool (mRNA, miRNA, lncRNA and other RNAs) was fragmented into pieces of approximately 
200 bp. The cleaved RNA fragments were reverse transcribed into first strand cDNA using reverse transcriptase 
and random primers. Next, the second strand was synthesized using DNA polymerase I and RNAseH. These 
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double-stranded cDNA fragments were end-repaired by T4 DNA polymerase and Klenow DNA polymerase, and 
phosphorylated by T4 polynucleotide kinase. The cDNA products were incubated with Klenow DNA polymerase 
to generate Adenine overhangs, therefore allowing ligation to Illumina indexing adapters to the double stranded 
cDNA ends. The adapter-ligated products were purified with Ampure XP magnetic beads (Agencourt Bioscience 
Corpo-ration, Beverly, MA, USA) and libraries were amplified by 15 cycles of PCR with Phusion DNA polymer-
ase (Thermofisher, Finnzymes Reagents, Vantaa, Finland). Constructed libraries were validated and quantified 
using BioRad’s automated electrophoresis system Experion and qPCR respectively. Pools of 6 indexed libraries 
were mixed (multiplexed) at equimolar ratios to yield a total oligonucleotide mix concentration of 10 nM. Finally 
the resulting libraries were sequenced on the Genome Analyzer IIx platform (Illumina) to generate 150 bp single 
reads. Six pooled indexed libraries were sequenced in each flow cell lane. Raw sequence (FASTQ format) were 
processed through a series of sequential steps: (1) aggressive adapters removal; (2) alignment/mapping of RNA 
sequences to the mouse genome reference (Mus_musculus.mm10) using tophat software; and (3) sorting and 
cataloguing of the results by using Samtools software14 in BAM files.
Gene expression analysis using WGCNA. BAM files were processed using the Rsubread package15 in 
the R environment16 and summarized to the mm10 version of mouse genome with the function featureCounts. 
Summarized readings by gene were then normalized using voom normalization17 to fit the count matrix into 
linear modelling with the package limma18 and to obtain log2 RPKM values. Whole read counts normalized 
were used to cluster samples with package hcluster using standard hierarchical cluster with average linkage. 
Heatmap visualization and clustering of DEG’s was done with Genesis software after expressing gene values in 
standard deviation and using hierarchical clustering with average linkage by genes and samples. Genecodis19 tools 
(http://genecodis.cnb.csic.es/) were used to obtain Gene Ontology and KEGG pathway terms enrichment using 
the adjusted p-value < 0.01 after an hypergeometric test. Finally, Reads per kilobase per million mapped reads 
(RPKM) filtered values (sum of RPKM > 2 for each gene) were introduced to the Weighted Correlation Gene 
Network Analysis (WGCNA) package in R, to perform WGCNA as previously described20. Briefly, combined 
samples were measured with the pickSoftThreshold function to obtain a correct power β considering the smallest 
value to give a free-scale topology. Using 18 as the power value, the blockwise function was used with parameters 
mergeCutHeight = 0.2 to obtain modules containing genes with high co-expression similarity. WGCNA soft-
ware then extracted the first principal component of the expression values of each module to obtain the module 
eigengene.
Differential Expressed Genes Analysis. To identify DEGs, the BAM files were analyzed using R-software 
packages easyRNAseq21 and DESeq22. The “Coverage vectors” for all genes of each sample were obtained using 
“easyRNAseq” and the UCSC.mm10 Mus musculus reference genome. Samples were grouped by phenotype (WT, 
WT-L, WT-L + I) and the expression for each locus. To find DEGs, this count matrix was analyzed using “DESeq” 
software, a method based on the negative binomial distribution, with variance and mean linked by local regres-
sion. For each phenotype comparison, the group base expression, the fold Regulation, the uncorrected p-value, 
and q-value (false discovery rate corrected p-value) for each gene were calculated. For each comparison, the list 
of DEGs with a q-value < 0.05 was analyzed using Genecodis tools to obtain Gene Ontology and KEGG path-
way23–25 enrichment as previously described. For the Signalling Pathway Impact Analysis (SPIA) of the DEGs, the 
Clusterview web software26 (https://pathview.uncc.edu/analysis) was used for data integration and visualization 
of alterations in several KEGG inflammatory pathways (Toll-like receptor signalling, NF-kappa B signalling, TNF 
signalling, Cytokine-cytokine receptor interactions) using default parameters.
Statistical and Power analyses. Statistical analyses of qRT-PCR data were performed using one-way 
ANOVA followed by Bonferroni post-test. Values of p < 0.05 were considered statistically significant. Results 
were represented as mean ± standard error of the mean (SEM). Experimental data were analyzed using GraphPad 
Prism 5.01 software.
Differential gene expression and WGCNA analyses were calculated using DEseq and WGCNA statistical 
R-packages software. For Statistical power calculation, the RNAseqPS software27 (https://cqs.mc.vanderbilt.edu/
shiny/RnaSeqSampleSize/) was used. Assumptions made were that prior data indicated that the minimum aver-
age read counts among the prognostic genes in the control group was 5, the maximum dispersion was 0.5 and the 
Gene Forward (5′ → 3′) Reverse (5′→ 3′)
Cmklr1 CAA CAG GAG CAG GGG ACC GA TTC CTC ACC CAC GAA GAC TGC
Csf3 AGA GCT GCA GCC CAG ATC ACC AGC TGC AGG GCC ATT AGC TTC A
Cybb ACT CCT TGG GTC AGC ACT GGC GCA ACA CGC ACT GGA ACC CCT
Il-6 CCA GTT TGG TAG CAT CCA TC CCG CAG AGG AGA CTT CAC AG
Nos2 GGC AGC CTG TGA GAC CTT TG GCA TTG GAA GTG AAG CGT TTC
Ptgs1 GTG CTG GGG CAG TGC TGG AG TGG GGC CTG AGT AGC CCG TG
Ptgs2 TGC AGA ATT GAA AGC CCT CT CCC CAA AGA TAG CAT CTG GA
Tnf TGA TCC GCG ACG TGG AA ACC GCC TGG AGT TCT GGA A
Rn18s GTA ACC CGT TGA ACC CCA TT CCA TCC AAT CGG TAG TAG CG
β-actin CAA CGA GCG GTT CCG ATG GCC ACA GGA TTC CAT ACC CA
Table 1. Primers used in this work.
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ratio of the geometric mean of normalization factors was 1. It was also supposed that the total number of genes 
for testing was 14500 and the top 300 genes were prognostic. Therefore, the present RNA sequencing experiment 
with 3 experimental subjects in each group can identify differential gene expression between two groups if the 
desired minimum fold change was 23.5. Then, it will be possible to reject the null hypothesis by using exact test 
with a statistical power of 80%. The FDR associated with this test was 0.01.
Literature Search. On 26th May 2018, the query terms “microglia AND RNA sequencing”, “microglia AND 
transcriptome” and “microglia AND RNA seq” retrieved 278, 205 and 54 results, respectively, from the Pubmed 
database (https://www.ncbi.nlm.nih.gov/pubmed/). The search was limited to studies published in English. A 
total of 7 reports have been selected according to their similarity in terms of treatment paradigm and microglial 
source to our study.
Results
RNA-Seq transcriptional analysis of primary microglia treated with LPS or LPS + FNγ. It is 
known that LPS alone or in combination with IFNγ, two widely used pro-inflammatory treatments, triggers 
significant changes in the microglia transcriptome. As depicted in Fig. 1A, Tnf, Csf3, Il-6, Cybb, Ptgs2 and Nos2 
expression is induced in microglia treated with LPS or LPS + IFNγ for 6 h, in comparison with vehicle-treated 
cells. However, other genes, such as Ptgs1 and Cmklr1 are downregulated. Interestingly, the addition of IFNγ to 
LPS seems to compensate the expression of some LPS-induced genes, such as Tnf, in a statistically significant 
manner; and of others, like Csf3, Cybb, Ptgs1 and Cmklr1, merely as a non-significant trend. This suggests that 
the two stimuli are not always additive; indeed, they can be compensatory. To establish a high-resolution tran-
scriptome profile of primary murine microglial cells in response to LPS and LPS + IFNγ, we performed RNA-Seq 
analysis. Three independent microglial cultures were treated with a vehicle, LPS or LPS + IFNγ; total RNA was 
isolated 6 h after treatment and analysed by RNA-Seq. RNA libraries and sequencing were prepared as described 
in the “Materials and Methods” section. Normalized data represented on a heatmap for the abovementioned 
genes show the same expression pattern as that observed in qRT-PCR experiments (Fig. 1B).
The strong effect of the treatments on microglial RNA expression was revealed by unsupervised cluster anal-
ysis using normalized counts (reads per kilobase million, RPKM). The 9 samples were grouped into three clearly 
differentiated clusters corresponding to the microglial cultures treated with vehicle (n = 3), LPS (n = 3) and 
LPS + IFNγ (n = 3). No outliers were detected (Fig. 2A).
WGCNA reveals that LPS and LPS + IFNγ induce 11 different expression patterns in microglial 
cells. WGCNA is a method used in systems biology to find clusters or modules of highly interconnected genes 
and their correlation to a trait, e.g., treatment20. In our RNA-Seq study, we used WGCNA to analyze the gene 
expression patterns, in response to LPS and LPS + IFNγ, of all 14337 genes detected in cultured microglia. Our 
analysis clustered the genes into 11 distinct modules, corresponding to 11 different expression profiles, which 
were coded by arbitrarily assigned colours (Fig. 2B). The numbers of genes in the modules were, in descending 
order: 9343 (turquoise), 1169 (blue), 886 (brown), 532 (yellow), 516 (green), 441 (red), 432 (black), 334 (pink), 
212 (magenta), 192 (purple) and 79 (green-yellow). Grey (201 genes) was reserved for outliers or unclustered 
genes that do not fit in any module. Branches in the hierarchical clustered dendrogram correspond to individ-
ual genes and the y-axis shows the distance between them, i.e. similarity, the more distant the less similar. Note 
that all genes in “blue”, “yellow” and “green” modules, as well as half of genes grouped in “black”, are clustered 
separately from the genes in the other modules. Furthermore, although some modules are well-defined, such as 
“yellow”, and most of “blue”, “brown” and “turquoise”, others are not.
The module eigengene can be used to summarize and represent the gene expression profile of a given module. 
Thus, barplots of the values of the module eigengene were used to represent the correlation between genes clus-
tered within a module and the effect that LPS and LPS + IFNγ had on their expression (Fig. 2C). To account for 
the different patterns of gene expression, we fitted two models of treatment orders into the WGCNA. For the first 
one, we considered the pattern of genes that are modified by LPS, but even more by LPS + IFNγ (i.e., treatment 
order: C, LPS, LPS + IFNγ). This model showed the “yellow”, “blue”, “black” and “turquoise” modules to be the 
most strongly correlated (Fig. 2D, first column). Next, to obtain the gene patterns that were more strongly affected 
by LPS than by LPS + IFNγ, we fitted the reverse treatment order (C, LPS + IFNγ, LPS) and checked for the mod-
ule correlation. In this case, the modules “blue” and “turquoise”, whose genes are upregulated or downregulated 
by both treatments, were again strongly correlated; but so were the “green” and “red” modules (Fig. 2D, second 
column). Therefore, genes grouped in the “yellow”, “blue”, “green”, “red”, “black” and “turquoise” modules were 
further analysed, to understand the biological significance of the gene expression patterns induced by LPS and 
LPS + IFNγ.
Ontological analysis of WGCNA differentially affected modules. The Genecodis platform19 was 
used to perform the ontological analysis of those genes clustered in the “yellow”, “blue”, “green”, “red”, “black” and 
“turquoise” modules. Specifically, we focused on Gene Ontology (GO) terms for Biological Process (BP) (Fig. 3) 
and on Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (Fig. 4).
Module “yellow” grouped together genes clearly upregulated only by LPS + IFNγ, such as the members of 
the GBP family: Gbp1, Gbp8 and Gbp10. These IFNγ-inducible GTPases are involved in defence responses to 
viruses and bacteria28. Interestingly, our analysis of this module resulted in an enrichment of “defence response 
to virus and protozoan” together with “cytokine-mediated signalling pathway” and “cellular response to IFNγ” 
GO terms (Fig. 3A). Furthermore, “cytokine-cytokine receptor interaction”, “chemokine signalling pathway” and 
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“JAK-STAT signalling pathway” are among the most enriched KEGG pathways (Fig. 4A). These results suggest 
that genes in “yellow” module are affected by IFNγ, rather than LPS.
Both treatments, LPS and LPS + IFNγ, markedly upregulated genes clustered in the “blue” module. Our anal-
ysis revealed that these genes are mostly involved in inflammatory and immune response, since 8 out of the 10 
most enriched GO terms were related to these biological processes (Fig. 3B). Actually, the “blue” module grouped 
together prototypical pro-inflammatory genes such as Tnf, Csf3, Il-6, Cybb, Ptgs2, Nos2, Il-1β, Il-12a and Il-12b. 
In this module, not only does IFNγ greatly affect gene expression, but so does LPS, since “cellular response to 
interferon-gamma”, “LPS-mediated signalling pathway” and “Toll-like receptor signalling pathway” were among 
the top-10 annotated GO terms and KEGG pathways (Figs 3B and 4B).
Genes found in the “green” module, i.e., genes upregulated by LPS but not by LPS + IFNγ, were also involved 
in inflammatory and immune responses (Fig. 3C). Since LPS alone greatly induces gene expression in this mod-
ule, “response to lipopolysaccharide” and “Toll-like receptor signalling pathway” stand out among the most 
enriched GO terms and KEGG pathways (Figs 3C and 4C). In contrast, genes downregulated only in response to 
LPS, and clustered in the “red” module, play a role in non-inflammatory processes like “transcription”, “metab-
olism” and “phosphorylation” (Fig. 3D). Our analysis showed that there were no significant enriched KEGG 
pathways in the “red” module.
Figure 1. Microglial gene expression is affected by LPS alone or together with IFNγ, 6 h after treatment. 
(A) Expression of Tnf, Csf3, Il6, Cybb, Ptgs2, Nos2, Ptgs1 and Cmklr1 was analysed by qRT-PCR in primary 
microglial cultures treated with vehicle (C), LPS (100 ng/mL) or LPS + IFNγ (1 ng/mL) for 6 h (n = 4 
independent experiments). Data are shown as mean + SEM. *p < 0.05; **p < 0.01; ***p < 0.001 compared 
with the respective control condition. ##p < 0.01; ###p < 0.001 compared with the corresponding LPS condition. 
(B) Heatmap of RNA-Seq data showing Tnf, Csf3, Il6, Cybb, Ptgs2, Nos2, Ptgs1 and Cmklr1 expression profiles. 
Values are represented as SD from the normalized average for each gene. Hierarchical Clustering (average 
linkage, Euclidean distance) grouped the samples into three clusters corresponding to vehicle (pink), LPS 
(magenta) and LPS + IFNγ (purple) conditions. Furthermore, the genes were grouped into two different clusters 
depending on whether the treatment increases (yellow) or decreases (orange) their expression.
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Figure 2. Treatment with LPS alone or together with IFNγ for 6 h induces 11 different expression patterns in 
primary microglia. (A) Hierarchical clustering of total RNA-Seq RPKM normalized values clearly separates 
the 9 samples according to treatment condition: Control, LPS and LPS + IFNγ. (B) WGCNA correlation 
dendrogram of genes. According to their expression pattern, the genes were grouped into 11 different modules 
identified by arbitrary colours, turquoise module was the largest and the green-yellow the smallest. Outliers 
or unclustered transcripts are grey. Genes grouped in the yellow, blue and green modules and half of the 
genes clustered in the black module are clustered separately from the genes present in the other modules. (C) 
Module eigengene barplots represent how expression of the genes clustered in the 12 modules was affected by 
treatments. (D) To account for the different patterns of gene expression, two models of treatment order were 
fitted to the WGCNA. Left column. First model of treatment order (C, LPS, LPS + IFNγ). Right column. Second 
model of treatment order (C, LPS + IFNγ, LPS). Correlation between gene expression and treatment effect is 
represented using a red-green gradient: dark-red, 1, being the most positive correlation and dark-green, −1, the 
most negative correlation. The correlation p-value for each module is shown in parentheses.
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The “black” and “turquoise” modules include genes whose expression is decreased by LPS + IFNγ or by both 
treatments, respectively. “Transcription”, “translation”, “transport”, “metabolism” and “phosphorylation” were the 
main biological processes affected in these modules (Fig. 3E,F). Furthermore, the “black” module KEGG path-
ways annotation revealed that genes with decreased expression after LPS + IFNγ treatment play important roles 
in phagocytosis (Fig. 4D). In fact, previous work by our group has demonstrated reduced microglial capacity to 
phagocytose bacteria after LPS + IFNγ treatment11, which is in accordance with this result. Meanwhile, analysis of 
genes downregulated by both LPS and LPS + IFNγ, clustered in the “turquoise” module, revealed “Huntington’s, 
Alzheimer’s and Parkinson’s disease” to be among the most significant affected KEGG pathways (Fig. 4E). Note 
that genes identified in this study and classified within these three pathways represent more than 60% of all the 
genes annotated in these diseases, indicating the high relevance of the data presented here.
Figure 3. Enrichment analysis of Gene Ontology (GO) terms (biological processes) in selected WGCNA 
modules. This figure shows the 10 most significantly enriched GO terms in the yellow (A), blue (B), green (C), 
red (D), black (E) and turquoise (F) modules. Gene percentage annotation (i.e., the percentage of the total 
number of genes annotated in each category that were detected in this work) is depicted on the upper x-axis; 
whereas the p-value is represented on the lower x-axis. The biological processes and the number of genes 
annotated within each of them are presented on the y-axis.
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In microglia, LPS and LPS + IFNγ downregulate Huntington’s, Alzheimer’s and Parkinson’s 
disease-related genes. Among the genes downregulated by the combination of both treatments, and sorted 
into the “turquoise” module, 119, 101 and 84 genes were annotated in Huntington’s, Alzheimer’s and Parkinson’s 
disease, respectively (Fig. 4E). In-depth analysis revealed that in total these represented 169 different genes. Of 
these, 64 were involved in all three neurodegenerative disorders, as depicted in the Venn Diagram (Fig. 5). Within 
these 64 common genes, there were different members of the gene families of ATP synthases, cytochrome c 
oxidases, NADH dehydrogenases, succinate dehydrogenases and ubiquinol-cytochrome c reductases. The Venn 
diagram also shows 15, 35 and 48 genes related exclusively to Parkinson’s, Alzheimer’s and Huntington’s disease, 
respectively.
Figure 4. Enrichment analysis of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in selected 
WGCNA modules. This figure shows the 10 most significantly enriched KEGG pathways23–25 in the yellow 
(A), blue (B), green (C), red (D), black (E) and turquoise (F) modules. Gene percentage annotation (i.e., the 
percentage of the total number of genes annotated in each category that were detected in this work) is depicted 
on the upper x-axis; whereas the p-value is represented on the lower x-axis. The biological processes and the 
number of genes annotated within each of them are presented on the y-axis.
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Park2, Park7 and Pink1 stand out among Parkinson’s disease-specific genes downregulated by both treat-
ments, since they are involved in biological processes characteristic of this disease, like dopamine uptake and 
neurotransmission, autophagy and degradation of mitochondria. Furthermore, our data reveal that Adam10, 
Apoe, App, Bace1 and Psen2 expression is decreased in microglial cells treated with LPS or LPS + IFNγ. These 
genes play a pivotal role in Nocht signalling, protein processing, apoptosis and beta-amyloid metabolic processes 
which are altered in Alzheimer’s disease. Finally, Bax, Hdac2 and Sp1, involved in apoptosis and transcription, are 
found among the Huntington’s disease-specific genes affected by LPS and LPS + IFNγ.
Differential  expression of coding and non-coding RNAs induced by LPS and 
LPS + IFNγ. WGCNA revealed that although some genes respond equally to LPS and LPS + IFNγ, others 
do not. In order to further characterize microglial response to both treatments, we studied those RNAs that are 
differentially expressed using DESeq analysis. This is a straightforward approach to detect genes differentially 
upregulated or downregulated by direct pairwise comparisons.
Figure 5. LPS and LPS + IFNγ downregulate 169 genes involved in Parkinson’s, Alzheimer’s and Huntington’s 
disease. The Venn diagram shows that as many as 64 of these genes are common to all three diseases. They 
belong to the gene families of ATP synthases, cytochrome c oxidases, NADH dehydrogenases, succinate 
dehydrogenases and ubiquinol-cytochrome c reductases. In turn, 15, 35 and 48 genes are specific to Parkinson’s, 
Alzheimer’s and Huntington’s disease respectively. Note the presence Park2, Park7 and Pink1 in Parkinson’s 
disease, Adam10, Apoe, App, Bace1 and Psen2 in Alzheimer’s disease and Bax, Hdac2 and Sp1 in Huntington’s 
disease.
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Taking into account all the samples, 14,337 coding and non-coding RNA species were detected. When ana-
lysed separately, 11,225, 12,694 and 13,004 protein-coding RNAs were identified in Control, LPS and LPS + IFNγ 
samples, respectively (Table 2). Among non-coding RNAs, long non-coding RNAs (lncRNAs) were particularly 
abundant. Micro-RNAs (miRNAs) represented only 6% of the non-coding RNAs detected. Finally, pseudogenes, 
small nucleolar RNAs (snoRNAs) and small nuclear RNAs (snRNAs) were also found. Note that treatments can 
turn gene expression on or off; therefore, the number of RNAs detected is different for each Control, LPS and 
LPS + IFNγ condition.
Data analysis revealed that LPS greatly influences protein-coding RNA expression, since 37% of these RNAs 
detected in primary microglia show significant changes compared to Control (Table 3). Upregulation versus 
downregulation is split roughly equally: 52.4% and 47.6% respectively. In addition, LPS turns on the expression 
of 32 protein-coding RNAs and turns off 27. LPS also tends to induce overexpression of non-coding RNAs, par-
ticularly snoRNAs and miRNAs, since none of them were downregulated by LPS.
Regarding expression changes induced by LPS + IFNγ when compared to Control, our results do not differ, 
in general terms, from those reported above for LPS: the percentage of affected RNAs and the numbers of those 
increased or decreased are similar, though snoRNAs are an exception. Comparison between LPS and LPS + IFNγ 
shows that 10% of coding RNAs are altered by IFNγ addition. Its effect can be synergistic or antagonistic to LPS, 
since the number of RNAs increased or decreased is similar.
Venn diagrams (Fig. 6) also prove to be a useful tool to evaluate overall similarities and differences between 
the changes induced by LPS and by LPS + IFNγ in primary microglia. The response of protein-coding RNAs to 
LPS is stronger than that to LPS + IFNγ, since 4,684 and 4,397 genes are affected, respectively. However, most of 
them are common, specifically 3011. An additional 935 are affected by LPS alone, whereas only 644 are affected 
by LPS + IFNγ alone. In contrast, when comparing LPS + IFNγ directly with LPS (not each treatment with 
Control) our results show that out of 1,086 protein-coding RNAs altered. Of them, 80 are exclusively affected by 
LPS + IFNγ compared to LPS. Interestingly, there are 474 protein-coding RNAs whose expression changes in all 
three comparisons: LPS versus Control, LPS + IFNγ versus Control and LPS + IFNγ versus LPS.
The effect of LPS activation is also notable in pseudogenes and lncRNAs, where once again many LPS-altered 
RNAs also respond to LPS + IFNγ co-treatment. miRNAs are quite particular, since only 6 are differentially 
expressed: mir-155, mir-221, mir-222, mir-22hg, mir-5111 and mir-1957a. Five of these are induced by both 
LPS and LPS + IFNγ, but only mir-1957a expression increases due to LPS + IFNγ. As opposed to protein-coding 
RNAs, pseudogenes and lncRNAs, no miRNA changed when comparing the two treatments directly.
LPS- and LPS + IFNγ-treated microglia share common features, but have distinct pheno-
types. Little is known about the biological functions of non-coding RNAs in microglia, except for a few 
miRNAs, such as mir-155, which was upregulated by both treatments in our analysis. Therefore, we focused 
on protein-coding RNAs to determine the similarities and differences between LPS- and LPS + IFNγ-activated 
microglia.
SPIA analysis of the DEGs26 provides the first clues to this question. We analysed separately all 4,684, 4,397 
and 1,086 DEGs affected in the LPS vs Control, LPS + IFNγ vs Control and LPS + IFNγ vs LPS comparisons, 
respectively. The Toll-like receptor signalling pathway was significantly affected in all of them. Interestingly, many 
genes involved in this pathway were upregulated by both LPS and LPS + IFNγ treatments (Fig. 7A). However, 
others including Tlr2, Tlr7 and Tlr8 were downregulated by LPS + IFNγ. A dampening effect of IFNγ was also 
observed in the case of inflammatory genes such as Tnf, Il-1β, IKKβ and Irf7, when comparing LPS + IFNγ to 
LPS (Fig. 7B).
More significant results were obtained when considering common and non-common DEGs separately. Nos2, 
Tnf, Tlr2, Tlr3, Il-1β, Il-18, Il-23a, Irf1, Irf7 and Irf8 were among the 474 coding RNAs differentially expressed in 
all three comparisons. These RNAs did not share the same expression profile, e.g., Nos2 expression increases due 
to both treatments but particularly with LPS + IFNγ; while LPS alone induced the highest Tnf expression. These 
findings are in accordance with the qRT-PCR results (shown in Fig. 1A). This expression heterogeneity is also 
Control LPS LPS + IFNγ
Protein-coding 11225 12694 13004
Non-coding RNAs 1104 1174 1169
  Pseudogenes 266 291 296
  lncRNAs
    lincRNA 117 123 124
    Antisense 140 144 140
    Processed transcripts 126 128 124
    Sense intronic 7 8 8
    snoRNA 68 79 81
    snRNA 7 7 9
    miRNA 69 66 63
    Miscellaneous RNA 52 53 52
Table 2. Number of protein coding and non-protein-coding RNAs detected in Control, LPS and LPS + IFNγ 
conditions. In all three cases, protein-coding RNAs represent about 90% of RNAs detected. Note that because 
treatments can switch on or switch off gene expression, numbers are different when comparing conditions.
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confirmed by WGCNA: 30%, 26%, 20%, 16%, 5% and 3% of the DEGs detected by DESeq are clustered within the 
“yellow”, “green”, “blue”, “turquoise”, “pink” and “red” modules, respectively. Even so, most of them are involved in 
inflammatory and immune responses, since 7 of the 10 most significant annotated GO terms were related to these 
processes (Fig. 8A). Thus, both treatments, LPS and LPS + IFNγ, trigger an inflammatory microglial phenotype.
Regarding non-common DEGs, 935 RNAs were affected only by LPS alone and 644 by LPS + IFNγ com-
pared to Control. Both treatments seem to be more prone to inhibit expression of these RNAs than to promote 
it. Thus, 502 RNAs were downregulated and 433 were upregulated due to LPS, whereas expression of 377 RNAs 
was decreased and that of 267 was increased in response to LPS + IFNγ (Fig. 6A). Once again, these expression 
patterns were in accordance with WGCNA results. 97% and 3% of genes downregulated only by LPS were found 
within the “turquoise” and “red” modules, whilst most of the upregulated genes were clustered in the “green” 
and “blue” modules. Meanwhile, the “turquoise” and “black” modules included all the genes whose expression 
decreased only as a result of LPS + IFNγ treatment; whereas the genes upregulated only by this treatment were 
clustered in the “blue”, “yellow” and “pink” modules. According to the GO analysis, most of the DEGs only 
affected by LPS or only by LPS + IFNγ were involved in transcription and regulation of transcription processes 
(Fig. 8B-E). Furthermore, since inflammatory and immune responses are also associated with shifts in metabo-
lism29, metabolic processes were also greatly altered by LPS and LPS + IFNγ.
Although these results suggest that LPS and LPS + IFNγ-treated primary microglial cultures are similar, 
note that the genes involved in the biological processes are different for each condition. On one hand, we found 
that LPS alone significantly downregulates the transcription factors Runx1, Klf10 and Klf11, but upregulates the 
small GTPase RhoA, oncogenes Myc and Bmi1, chromatin remodelling factor Mta2 and membrane receptor 
Trem1 (Fig. 9A). On the other hand, LPS + IFNγ significantly decreases expression of the small GTPase RhoB, 
membrane receptor P2x4r, transcription factor Mef2d and non-histone nuclear DNA-binding protein Hmgb1. 
Additionally, LPS + IFNγ also increases the expression of the moonlighting protein Gapdh, sirtuin Sirt1, histone 
deacetylase Hdac9 and epigenetic regulator Mecp2 (Fig. 9B).
Finally, only 80 RNAs were differentially expressed when directly comparing LPS + IFNγ to LPS. Of these, 39 
were downregulated and clustered in the “black” (82%) and “turquoise” (18%) modules. The remaining 41 were 
upregulated and found within the “red” (94%) and “pink” (6%) modules (Fig. 6A). Because of the small number of 
affected genes, little can be inferred from analysis of the GO terms associated with these genes (data not shown).
Discussion
LPS alone or together with IFNγ is widely used to trigger microglial activation. However, to the best of our 
knowledge, similarities and differences between the effects of these two treatments on microglial gene expression 
have not been fully characterized. In the present study, to address this, we analysed the transcriptomic profile of 
primary microglial cells in response to LPS and LPS + IFNγ by RNA-Seq.
Determination of the time point used in this study was a significant initial step. Evidence shows that not all 
genes are expressed at once, but each has its own specific temporal expression pattern. Using LPS-treated primary 
microglia and BV2 cells, Das and colleagues12,30 reported that the most significant expression changes occur 
within the first and the eighth hour after treatment. We also previously described a marked gene upregulation 
LPS vs Control LPS + IFNγ vs Control LPS + IFNγ vs LPS
Upregulated Downregulated TOTAL Upregulated Downregulated TOTAL Upregulated Downregulated TOTAL
n ON n OFF n % n ON n OFF n % n ON n OFF n %
Protein-coding 2456 32 2169 27 4684 37% 2312 46 2021 18 4397 33.8% 532 1 549 3 1085 10%
Non-coding RNAs
Pseudogene 13 0 4 0 17 14% 11 0 2 0 13 10.8% 1 0 2 0 3 3%
Pseudogene polymorphic 1 0 0 0 1 33% 1 0 0 0 1 33.3% 0 0 0 0 0 0%
Pseudogene processed 19 0 3 1 23 16% 17 0 2 0 19 13.2% 1 0 1 0 2 2%
Pseudogene unprocessed 7 0 5 0 12 41% 8 0 3 0 11 37.9% 1 0 1 0 2 8%
lncRNA
  lincRNA 18 1 10 2 31 25% 18 1 9 1 29 23.4% 2 0 3 0 5 4%
  Antisense 21 1 9 0 31 22% 14 0 6 0 20 14.3% 1 0 2 0 3 2%
  Processed
  transcript 14 0 6 0 20 16% 13 0 5 0 18 14.5% 2 0 2 0 4 3%
  Sense intronic 1 0 0 0 1 13% 1 0 1 0 2 25.0% 0 0 0 0 0 0%
miRNA 5 0 0 0 5 7% 6 0 0 0 6 9.4% 0 0 0 0 0 0%
snoRNA 5 0 0 0 5 6% 0 0 0 0 0 0.0% 0 0 0 0 0 0%
miscRNA 27 1 13 2 43 83% 27 1 11 2 41 80.4% 0 0 5 0 5 10%
Unknown 16 0 7 1 24 13% 15 0 8 0 23 12.2% 3 0 3 0 6 3%
Table 3. LPS and LPS + IFNγ markedly affect primary microglia gene expression. DEGs in LPS versus Control, 
LPS + IFNγ versus Control and LPS + IFNγ versus LPS comparisons are showed. For each RNA species, 
the number of upregulated and downregulated RNAs is depicted. Switched ON/OFF RNAs are considered 
separately. Total genes affected are the sum of all four categories. Total percentage indicates the number of genes 
differentially expressed to the total number of genes detected in each RNA type.
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in cultured microglia treated with LPS and LPS + IFNγ for 6 h11,31,32. In this study, our qRT-PCR results showed 
significant alterations of canonical pro-inflammatory genes, such as Tnf, Csf3, Il-6, Cybb, Ptgs2 and Nos2, 6 hours 
after treatment. The expression profile of these genes was also observed after analysing RNA-Seq data, thus vali-
dating the high-throughput sequencing.
We are aware that analysing a single time point is a limitation of this study. Nevertheless, the data presented 
here for 6 hours after treatment offer a good picture of the first wave of transcriptional changes induced by LPS 
or LPS + IFNγ which are mainly regulated by latent transcription factors33. The relative timing of IFNγ and 
LPS exposure was also important. We decided to use co-treatment because this procedure results in a strong 
potentiation of LPS-induced NO production and neurotoxic effects10,34. Priming with IFNγ could have resulted 
in a somewhat different pattern of modulation, including a stronger potentiation on the production of some 
pro-inflammatory cytokines like TNFα35.
Genes or proteins that are directly linked might have a similar function and therefore may be part of the 
same biological pathway. More and more, network methods such as WGCNA are chosen to analyse these inter-
actions20. This approach classifies the whole transcriptome into discernible expression patterns. Furthermore, it 
compares all genes in the data and takes into account all changes through all samples at the same time. Therefore, 
it can extract complex expression profiles that could be easily missed if only DESeq pairwise differential expres-
sion analysis was used to examine the biological relevance of RNA-Seq data. Therefore, we used WGCNA to 
Figure 6. Differentially expressed RNAs affected by either or both of LPS and LPS + IFNγ. Venn diagrams 
showing the number of protein-coding RNAs (A), pseudogenes (B), lncRNAs (C) and miRNAs (D) significantly 
affected by LPS or LPS + IFNγ in primary microglia as assessed by DESeq analysis. Note the large number of 
protein coding genes significantly affected by both LPS and LPS + IFNγ; but also the existence of many genes 
specifically affected by LPS or LPS + IFNγ.
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organize gene expression data in order to establish clusters or modules of genes with similar responses to LPS 
and LPS + IFNγ treatments. Our results show that these two stimuli, both considered pro-inflammatory, do not 
affect all transcripts in the same way, since 11 different gene expression patterns were detected. The results also 
show that while some genes are affected by both treatments, others are only affected by LPS or LPS + IFNγ, which 
means that LPS and LPS + IFNγ do not always affect a given gene in the same way. We consider these observa-
tions to be relevant findings. Frequently, reports only focus on gene upregulation due to pro-inflammatory stim-
uli12,36. However, according to our data, 9,343 genes out of 14,337 tend to be downregulated, without this trend 
emerging as statistically significantresult, by both treatments. Furthermore, in other studies, microglia are only 
treated with LPS + IFNγ, as strong pro-inflammatory stimuli, without considering a potential antagonistic effect 
between LPS and IFNγ37,38.
According to GO analysis, the genes that are upregulated by pro-inflammatory stimuli in cultured microglia 
show a significant enrichment of GO terms related to inflammatory and immune responses. The annotation of 
these functions in response to LPS and/or LPS + IFNγ is interesting and indicates that our approach of comparing 
Figure 7. Toll-like receptor signalling pathway shows similarities, but also differences between LPS and 
LPS + IFNγ. (A) Genes involved in Toll-like receptor signalling affected by LPS (left side of the square) 
or LPS + IFNγ (right side of the square) compared to control. (B) This graph shows the genes within the 
pathway that are significantly altered when comparing LPS + IFNγ to LPS. Red indicates upregulation; green 
downregulation. Data on KEGG graph23–25 were rendered using Pathview.
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both treatments is strong but rather predictable. To the best of our knowledge, a comprehensive transcriptional 
profile of LPS + IFNγ-treated microglia has not been derived using RNA-seq, though the mouse embryonic stem 
cell-derived microglia response to this stimulus has been analysed via RNA microarrays39. Those data showed 
an exacerbated immune response and increased pro-inflammatory gene expression. Other reports also identify 
alterations in inflammatory and immune system processes, as well as a marked upregulation of pro-inflammatory 
genes, such as Ptgs2, Tnf, Il-12a and Il-1β, in the BV2 microglial cell line, primary microglial cultures and acutely 
isolated microglia from adult CNS treated with LPS (Table 4). Altogether, this is in agreement with our results.
Downregulated genes due to pro-inflammatory treatments are often overlooked because they are not thought 
to be involved in inflammation12,36. Here, we show that most genes expressed in non-activated primary micro-
glia are repressed when these cells are activated by LPS or LPS + IFNγ. Transcription, translation, metabo-
lism, transport, apoptosis and phosphorylation were the main biological processes in which the genes that are 
Figure 8. LPS and LPS + IFNγ are involved in similar biological functions, but some differences exist. This 
figure shows the 10 most enriched GO terms in: (A) genes common to LPS vs Control, LPS + IFNγ vs Control 
and LPS + IFNγ vs LPS (n = 474); (B) Genes only downregulated in LPS vs Control (n = 502). (C) Genes only 
upregulated in LPS vs Control (n = 433). (D) Genes only downregulated in LPS + IFNγ vs Control (n = 377). 
(E) Genes only upregulated in LPS + IFNγ vs Control (n = 267). Note that 7 of the 10 GO terms in (A) are 
related to immune and inflammatory responses. ((B–E) Share metabolism and transcription as the biological 
processes affected; but LPS tends to alter cell cycle (B) and LPS + IFNγ chromatin modifications (E). Gene 
percentage annotation (i.e., the percentage of the total number of genes annotated in each category detected in 
this work) is depicted on the upper x-axis, whereas the p-value is represented on the lower x-axis. The GO terms 
and the number of genes annotated within each of them are presented on the y-axis.
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downregulated by one or both treatments were involved. These results relativize the concept of resting microglia 
in physiological conditions.
Interestingly, 169 genes downregulated by both treatments were involved in three neurodegenerative pathol-
ogies: Huntington’s, Alzheimer’s and Parkinson’s disease. Common features of these disorders include abnormal 
protein aggregation, oxidative stress and mitochondrial dysfunction40. Indeed, 64 downregulated genes play a 
role in all three diseases; most of them belong to gene families involved in ATP synthesis through the mito-
chondrial electron transport chain. According to previous reports, inhibition of the mitochondrial respiratory 
chain enhances mitochondrial ROS production41. Therefore, downregulation of genes involved in the electron 
transport chain due to LPS and LPS + IFNγ treatments in microglia could lead to cellular damage and death of 
neighbouring cells due to ROS overproduction. Thus, activating primary microglia with both stimuli could be an 
experimental model to study this process.
CNS inflammation plays a role in the progression of chronic neurodegenerative diseases and this inflamma-
tory response is mostly governed by microglia42. In agreement with our results, LPS downregulates the E3 ubiq-
uitin ligase Park2 in microglial cells43, which leads to the accumulation of Tnf, Il-1β and Nos2. Park7-deficient 
microglia also show higher levels of Tnf, Nos2 and Ptgs244. Finally, Pink1 deletion exacerbates microglial activa-
tion45. Thus, downregulation of these genes could promote a pro-inflammatory microglial phenotype, thereby 
contributing to neurodegeneration in Parkinson’s disease.
Figure 9. A model of specific signalling pathways triggered by LPS and LPS + IFNγ in primary microglia. (A). 
By upregulating genes like Mta2, Bmi1, Myc, RhoA and Trem1 and downregulating Runx1, Klf10 and Klf11, LPS 
promotes microglial proliferation, phagocytosis and the release of pro-inflammatory cytokines. (B). LPS + IFNγ 
induces expression of Gapdh, Sirt1, Hdac9 and Mecp2, whereas it reduces that of Mef2d, P2xr4, RhoB and 
Hmgb1. This suggests that LPS + IFNγ-treated microglia have less proliferative potential, show reduced 
expression of genes involved in neuropathic pain and are more prone to resolve inflammation by activation of 
oxidative respiration and blockade of pro-inflammatory cytokine production.
www.nature.com/scientificreports/
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Reference Microglia source Treatment conditions Main findings
12 BV2 microglial cell line LPS for 2 and 4 h
367 DEGs, 2 h after LPS treatment, 263 ↑ and 104 ↓.
512 DEGs, 4 h after LPS treatment, 319 ↑ and 193 ↓.
Most induced genes, such as Nos2, Il-1α, Il-1β, Tnf, 
Ptgs2, Ir1, Ir7, Ir9 and Cxcl10, were involved in immune 
system, response to stimulus, multiorganism processes 
and death biological functions.Markedly decreased 
genes, like Irak1, Cxcr4, Hdac9 and Tlr8, participate 
in regulation of biological and cellular processes and 
development regulation processes.
30 BV2 microglial cell line
Mouse primary microglia (PM) LPS for 2 and 4 h
BV2 microglial cell line is poorly representative of PM.
In response to LPS a much larger number of transcripts 
was altered in PM than in BV2:
In PM, 531 DEGs were affected 2 h after LPS treatment 
(362 ↑, 169 ↓), whereas 4 h treatment altered 1286 
DEGs(946 ↑, 340 ↓).
Exposure to LPS altered 237 DEGs (205 ↑, 32 ↓) after 2 h 
and 331 DEGs (299 ↑, 32 ↓) after 4 h, in BV2.
Still, some similarities were observed, e.g. BV2 and 
PM shared 142 and 264 upregulated DEGs at 2 and 
4 h, respectively. Furthermore, the top 150 upregulated 
genes after 4 h LPS exposure were involved in immune 
system, multiorganism processes, locomotion, response 
to stimulus and cell killing processes in both cell types.
39
Mouse primary microglia
Mouse embryonic stem cell-
derived microglia (ESdM)
LPS + IFNγ for 16 h
IL-4 and TGF-β for 48 h
LPS + IFNγ, IL-4 and TGF-β for 
24 h
In ESdM, the strongest transcriptome changes were 
induced by LPS + IFNγ. Most upregulated genes 
include Nos2, Tnf, Socs1, Socs3, Stat1, Marco, CD80 and 
Icam1, whereas Arg1 and Mrc1 were downregulated.
LPS + IFNγ GO-terms were related to immune 
functions.
IL-4 GO-terms related to metabolic and catabolic 
processes.
TGF-β GO-terms linked to angiogenesis, cell motility 
and metabolism.
ESdM closely resembles PM on whole transcriptome, 
although response to LPS + IFNγ was weaker.
72 Ovine foetus primary microglia LPS for 6 h
258 DEGs due to LPS treatment were found. Of them, 
205 were upregulated (e.g. Il-1a, Irf7, Jak3, Ptges) and 53 
were downregulated (e.g. C/EBPα, Hmox1, Cxcr4)
LPS upregulated NFκB, PIK3-Akt and JAK-STAT 
inflammatory pathways, but downregulated metabolic 
processes
73 Human primary microglia
IFNγ for 1 h + LPS for 48 h (M1)
IL-4 + IL-13 for 48 h (M2a)
IL-10 added to M2a at 24 h + 144 h 
(M2c)
TGF-β added at 24 h + 120 h (Mtgf)
Mtgf closely resembles basal microglia (M0).
M1 transcriptome most distinct from M0 (837 genes 
were induced, including mir-155, and 618 were 
reduced).
M1 stimuli lead to an almost complete loss of myelin 
phagocytic activity
(Mtgf > M2c > M2a = M0 > M1)
54 Acute isolated cortical 
microglia from adult mouse Intraperitoneal LPS for 24 or 48 h
10788 genes were detected. Of them, 4179 were 
significantly altered by LPS (50% ↑, 50% ↓).
Top-3 deregulated pathways were Eif2 signalling, 
mitochondrial dysfunction and protein ubiquitination 
pathway.
Affected inflammatory pathways include Il-10, Tnfr2 
and NFκB signalling pathways.
LPS also altered non-inflammatory pathways, such as 
androgen signalling and Huntington’s disease.
Cell death and survival, cellular growth and 
proliferation, cellular function and maintenance and 
gene expression were among most enriched GO-terms. 
However, 38% of deregulated genes were related to the 
microglia ability to sense their environment.
74 Acute isolated microglia from 
adult mouse CNS
Intraperitoneal LPS for 4 h
Aging models:
Physiological aging (4 and 24 
months)




Amyotrophic Lateral Sclerosis, 
Sod1
Aging and neurodegeneration share a gene expression 
profile, particularly in upregulation, which substantially 
differed from the inflammatory gene network induced 
by LPS.
Genes altered in aging and neurodegeneration were 
involved in immune, phagosome, lysosome, oxidative 
phosphorylation and antigen presentation signalling 
pathways.
LPS enriched for ribosome, TLRs and NOD-like 
receptor signalling pathways.
Despite their dissimilarities, Tlr2, Il-1β, Cxcl10 and 
Spp1 genes, related to innate immune response, were 
upregulated in all 5 models.
Table 4. Relevant previous microglial transcriptomic studies. The effect of LPS and LPS + IFNγ on microglia 
transcriptome has been previously addressed using different cell sources: BV2 cell line, primary culture, 
mouse embryonic stem cell-derived microglia or acute isolated microglia from adult CNS. Reports describe 
an exacerbated inflammatory and immune response due to the treatments, as well as upregulation of pro-
inflammatory genes. Furthermore, genes involved in metabolic processes tend to be downregulated by LPS. 
These findings are in accordance with the results here presented. Comparison between LPS and LPS + IFNγ-
treated microglia transcriptomes was not the central topic of these studies.
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Activated microglia induce neuronal cell death through the release of cytotoxic factors including cytokines 
and ROS in Alzheimer’s disease46. Interestingly, the “cytokine activity”, “defence response” and “T-cell activa-
tion” GO terms were associated with upregulated genes in an RNA-Seq analysis performed in sorted microglia 
from 15 to 18 month-old APP/PS1 transgenic mice47. Furthermore, that report showed downregulation of ApoE 
expression, similar to our data presented here. It was possible to revert this process, which is highly impaired in 
Alzheimer’s disease, by co-culturing neonatal microglia in brain slices of 20 month-old APP/PS1 mice. Therefore, 
a comparison between young and old microglia transcriptomic profiles could provide some clues as to which pro-
cesses are impaired with age and lead to disease. Little is known about Adam10, App, Bace1 and Psen2 microglial 
expression. Nevertheless, due to their involvement in Alzheimer’s disease pathophysiology, it would be worth fur-
ther studying the implications of their downregulation in response to LPS and LPS + IFNγ. Similarly, decreased 
expression of the Huntington’s disease-related genes Sp1, Hdac2 and Bax, as a result of both treatments could 
provide some clues about the underlying disease mechanisms.
This study was performed with primary microglial cultures isolated from neonatal mouse cortex. Although 
this model is widely used and has contributed considerably to our current knowledge on microglial biology, 
it is important to be aware of its limitations. As with most cell types, in vitro culture has an impact on micro-
glial biology. Gosselin and colleagues48 reported significant transcriptomic changes in human and mouse brain 
microglia when cultured. The transfer of cells to the in vitro environment resulted in 10-fold induction of more 
than 300 genes and 10-fold reduction of more than 700 genes after 7 days. Although cultured microglial cells 
show an activated phenotype, they become less responsive after 13–16 days in vitro (DIV)49,50. The microglial 
cultures in this study were used at 21 DIV. This relatively long time in culture allows microglia to mature and 
become less reactive, particularly because of their interactions with astrocytes. Be that as it may, it is important 
to acknowledge that the lack of neuronal inhibitory inputs probably results in microglia being in a more acti-
vated state than in the adult CNS in vivo. Another caveat to be added to this study is that microglial cells were 
isolated from the brains of early neonates. This allows for the preparation of microglial cultures with a high yield 
in a simple and reproducible manner. However, since early postnatal microglial cells differ from adult or aged 
microglia in terms of morphology, function and gene expression51, caution must be exercised when interpreting 
our data. Recent improvements in the isolation of fresh microglia using fluorescence-activated cell sorting and 
laser capture microdissection methods have been reported52. Such methods have the advantage over cultures that 
microglial cells live in their physiological environment until the moment of extraction, but they are not free from 
artefacts. The isolation procedure for fluorescence-activated cell sorting requires 3 to 5 hours, which may affect 
the expression profile of microglia. In contrast, cellular lysis in cultured microglia is immediate and the transcrip-
tome obtained faithfully reflects the transcriptome of the living cells, which also occurs with RNA from microglia 
isolated by laser capture microdissection. A main drawback of RNA from microglia isolated by laser capture 
microdissection is the probable presence of RNA from surrounding cells. In this respect, the purity of cultured 
microglia RNAs is far superior. As has been stated before, it is critical to be aware of the limitations of the protocol 
used and choose the method most appropriate for the scientific question addressed53. Despite their limitations, 
LPS- or LPS + IFNγ-treated microglial cultures allow a considerable experimental versatility and provide valuable 
information on the potential phenotypes of activated microglia.
Apart from revealing the inhibition of important genes implicated in neurodegenerative diseases in cultured 
microglial cells treated with LPS or LPS + IFNγ, the present RNA-Seq analysis also allowed us to gain further 
understanding of how both stimuli affect microglial gene expression. Thus, DEGs were obtained using DESeq 
analysis. Both protein-coding and non-protein-coding RNAs were found; although protein-coding transcripts 
represented 90% of all RNAs detected. Among the non-protein-coding RNAs, few miRNAs were detected because 
the sequencing protocol used here only allows for the detection of pre-miRNAs. Thus, the data presented here 
show only a small fraction of the miRNAs present in primary microglial cells. To conduct a specific study of miR-
NAs, another sequencing library preparation protocol should be used.
LPS and LPS + IFNγ have a slightly greater tendency to upregulate gene expression than to downregulate 
it in all the transcripts differentially expressed. This slight difference between the number of genes upregulated 
and those downregulated, though in accordance with Hirbec et al.54, differs from most previous microglial 
RNA-Seq analysis, where most of the affected genes were upregulated (Table 4). These differences may be due to 
different time points, treatment doses or microglia sources being used. The number of samples can also lead to 
discrepancies30.
Because information on non-protein-coding RNAs is scant, the functional significance of their expression 
changes due to treatments in microglial biology was not further considered in this work. Instead, we focused on 
protein-coding RNAs. LPS versus Control and LPS + IFNγ versus Control comparisons shared more than 3000 
DEGs. Moreover, another 474 DEGs were common to these two comparisons and also to the LPS + IFNγ versus 
LPS comparison. Most of these genes, including Nos2, Tnf, Tlr2, Tlr3, Il-1β, Il-18, Il-23a, Irf1, Irf7 and Irf8, are 
involved in inflammatory and immune responses, thus validating the usefulness of LPS and LPS + IFNγ to induce 
and study microglial activation in vitro. For this reason, they are sometimes used interchangeably. A detailed look 
into the genes differentially affected only by LPS and LPS + IFNγ, together with a comprehensive review of the 
literature, has allowed us to better understand the different signalling pathways affected under each condition.
The transcription factor Runx1 is sufficient to inhibit microglia activation in response to LPS treatment. Runx1 
acts in amoeboid microglia to limit the length of the activated phase and guide the cells toward a deactivated phe-
notype. Moreover, this transcription factor inhibits the proliferative capacity of amoeboid microglia55. Through 
its target Bmi1, Runx1 is involved in cell self-renewal and its depletion increases Bmi1, thereby inducing cell pro-
liferation56. It seems probable that, LPS downregulates Runx1 expression by increasing Mta2: a member of NuRD 
complex57. Therefore, Bmi1 expression is upregulated, which suggests the existence of a proliferative microglial 
phenotype in response to this treatment (Fig. 9A). The activation of the oncogene Myc also supports this hypoth-
esis. Klf10 and Klf11 decrease cell proliferation and induce apoptosis by targeting Myc58. LPS treatment not only 
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downregulates Klf10 and Klf11 genes in microglia, but also in bone marrow-derived macrophages. This inhibition 
enhances Il-12b expression59. Inflammation is also elicited by the upregulation of the small GTPase RhoA, since 
it promotes superoxide release60. RhoA also induces microglial phagocytosis of apoptotic neurons61, whereas 
Trem1 favours microglial Aβ uptake62. Therefore, LPS triggers a proliferative, pro-inflammatory and phagocytic 
microglial phenotype.
The NAD-dependent deacetylase Sirt1 is a crucial regulator of energy metabolism and cell survival. It sup-
ports oxidative respiration and anti-inflammatory responses, thus enhancing the resolution of inflammation63. 
Gapdh promotes Sirt1 activation and autophagy initiation which protect cells from apoptosis induced by glucose 
withdrawal64. Thus, through Gapdh, LPS + IFNγ could enhance Sirt1 expression (Fig. 9B). LPS + IFNγ-activated 
microglia seem to be non-proliferative and non-motile, since Sirt1 blocks microglial proliferation65 and the 
small GTPase RhoB, which induces cell migration, is downregulated by the co-treatment66. After spinal cord 
injury, RhoB is co-expressed with the purinergic receptor P2x4r in microglial cells. This receptor is a major con-
tributor to the development of neuropathic pain. Therefore, P2x4r downregulation due to LPS + IFNγ could 
be related to pain reduction. This stimulus is also involved in chromatin structure. Sirt1 and Hdac9 are histone 
deacetylases and Mecp2 participates in histone methylation. All three upregulated genes participate in inflam-
matory responses. Sirt1 suppresses the release of pro-inflammatory cytokines65. Meanwhile, Hdac9 binds and 
represses the transcription factor Mef267, which in later stages of microglial activation promotes IL-10 release68. 
Finally, Hmgb1 interacts with and represses Mecp269. However, LPS + IFNγ downregulates Hmgb1, thus increas-
ing Mecp2 expression and blocking secretion of pro-inflammatory mediators70,71. Thus, these results suggest that 
LPS + IFNγ treatment reduces genes involved in neuropathic pain, as well as microglial migration and prolifera-
tion, whereas it also promotes some anti-inflammatory responses.
Altogether, it seems that the addition of IFNγ could, somehow, dampen some pro-inflammatory genes. 
Downregulation of inflammatory mediators and effectors, such as that of Tnf, Il-1β, IKKβ and Irf7 observed in 
Toll-like receptor signalling pathway analysis when comparing LPS + IFNγ and LPS, supports this hypothesis. 
To confirm it, an additional experimental group, IFNγ-treated microglia, should have been included. This is 
certainly a limitation of the study.
Conclusions
In summary, by using RNA-seq, we have compared the transcriptomic changes induced by LPS and LPS + IFNγ 
in primary murine microglia. Our study demonstrates that both treatments greatly affect microglial gene expres-
sion. However, not all genes are equally affected by LPS and LPS + IFNγ. Interestingly, both treatments downreg-
ulate genes involved in Parkinson’s, Alzheimer’s and Huntington’s disease. These data break new ground in the 
study of the role of microglia in these disorders. Furthermore, a detailed look at the genes differentially expressed 
only by LPS or LPS + IFNγ has revealed that LPS-treated microglia are proliferative, phagocytic and release 
pro-inflammatory cytokines. In contrast, LPS + IFNγ reduces cell proliferation, downregulates genes involved in 
pain and favours resolution of inflammation. These different profiles must be taken into account when using LPS 
or LPS + IFNγ in in vitro models of microglial activation.
Ethics approval. All procedures involving animals were approved by the Ethical Committee for Animal 
Experimentation of the Universitat de Barcelona and by the Commission for Animal Experimentation of the 
Generalitat de Catalunya, with protocols numbers DAAM 5026, 7064 and 7065.
Availability of Data and Materials
RNAseq datasets were deposited in the Gene Expression Omnibus database under dataset accession number 
GSE90046. Note that this dataset also includes samples from our previous work11. However, no overlap analysis 
exists between both reports. Samples here analyzed can be found as C/EBPβfl/fl genotype, considered wild-type. 
Other data supporting the conclusions of this study will be available upon reasonable request.
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